Sign in

CIK 0001862150 · <br>Emerging growth company

Cingulate Inc.

Sign in to watch
Ticker
CING
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863825535
Phone
(913) 942-2300
Business address
1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
Former names
Cingulate Inc.

Securities

  • CING Common Stock Nasdaq
  • CINGW Warrants Nasdaq
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Executive or director change · Shareholder vote results
  13. 8-K Event Agreement ended
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. DEFA14A Proxy Proxy Materials
  17. ARS Other Annual Report to Security Holders
  18. DEF 14A Proxy Proxy Statement
  19. PRE 14A Proxy Proxy Statement (Preliminary)
  20. 8-K Event Material agreement · Regulation FD disclosure

Page 6 of 25 · 494 filings